Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*Daniela Berg, Thomas Gasser, Katherine J. Schweitzer et al.|Brain|2005Cited by 263
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trialJohannes Levin, Johannes Schwarz, Claudia Trenkwalder et al.|The Lancet Neurology|2019Cited by 126
Alpha‐synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patientsDaniela Berg, Olaf Rieß, Marc Niwar et al.|Movement Disorders|2005Cited by 75